TRCT
GRDN

Tower Research Capital (TRC)’s Guardian Pharmacy Services GRDN Stock Holding History

Tower Research Capital (TRC)’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80.9K Buy
1,932
+455
+31% +$17.6K ﹤0.01% 2354
2026
Q1 		$55.6K Buy
1,477
+93
+7% +$3.04K ﹤0.01% 2653
2025
Q4 		$41.6K Buy
1,384
+300
+28% +$8.49K ﹤0.01% 2566
2025
Q3 		$28.4K Sell
1,084
-392
-27% -$9.34K ﹤0.01% 2991
2025
Q2 		$31.5K Buy
1,476
+917
+164% +$20.7K ﹤0.01% 3361
2025
Q1 		$11.9K Buy
559
+69
+14% +$1.42K ﹤0.01% 3493
2024
Q4 		$9.93K Buy
+490
New +$10.1K ﹤0.01% 3859

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
VCM
Valiant Capital Management San Francisco, California $2.48B AUM 57.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Tower Research Capital (TRC)'s GRDN Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Guardian Pharmacy Services (GRDN) stake by 31% in Q2 2026, buying an estimated $17.6K and bringing the position to 1,932 shares worth $80.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2354.

Tower Research Capital (TRC) first reported a position in GRDN in Q4 2024 and has held it in 7 quarters since. 190 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • Tower Research Capital (TRC) held 1,932 shares of Guardian Pharmacy Services worth $80.9K as of Q2 2026.
  • Tower Research Capital (TRC) bought 455 Guardian Pharmacy Services shares in Q2 2026, an estimated $17.6K.
  • Guardian Pharmacy Services made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #2354 holding.
  • Tower Research Capital (TRC) first reported a position in Guardian Pharmacy Services in Q4 2024 and has held it in 7 quarters since.
  • 190 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.